Urology Research & Practice
ANDROLOGY - Invited Review

Infertility as a Proxy of Men’s Health: Still a Long Way to Go

1.

Division of Experimental Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milano, Italy

2.

Department of Urology, Foundation IRCCS Ca’ Granda-Ospedale Maggiore Policlinico, University of Milano, Milano, Italy

3.

Department of Urology and Andrology; Ospedale di Circolo and Macchi Foundation, Varese Italy

4.

University Vita-Salute San Raffaele, Milano, Italy

Urol Res Pract 2023; 49: 73-78
DOI: 10.5152/tud.2021.20561
Read: 715 Downloads: 206 Published: 01 March 2023

Male infertility (MI) has been widely associated with the development of certain comorbidities and to a lower overall general health status. Higher risks of developing oncological, autoimmune, and chronic disorders among infertile individuals have led researchers to further investigate this issue. Recent clinical studies have been focusing more onto the concept of general health status and mortality. Overall, it has been postulated and subsequently demonstrated that the coexistence of specific diseases and semen alterations may lead to a decreased lifespan. As in Western countries, fatherhood is increasingly delayed in time, and aging might play an important role as a confounding factor for the after-mentioned statements. Although this holds true, even after adjusting for age, it emerges a worrisome picture regarding MI, lower general health status, and increased mortality. The aim of this nonsystematic narrative review is to provide an overview of the most relevant and recent findings on the topic. 

Cite this article as: Pozzi E, Boeri L, Capogrosso P, Candela L, Cazzaniga W, Belladelli F, et al. Infertility as a Proxy of Men’s Health: Still a long way to go. Urol Res Pract., 2023;49(2):73-78.

Files
EISSN 2980-1478